Centene Corporation (CNC) fair value analysis

S&P 500 · Updated 2026-09-07

Centene Corporation is a managed care company that provides health insurance coverage and related services to individuals, including those enrolled in Medicaid, Medicare, and marketplace plans. The company operates across the United States and serves millions of members through its various health plans and subsidiaries.

Forward Fair Value verdict

Overvalued

Based on TickrTrends' weekly Forward Fair Value model, CNC is trading at a 10–25% premium to estimated fair value.

CNC currently ranks #96 of 113 Healthcare stocks by discount to Forward Fair Value. It has screened as Overvalued for 3 consecutive weekly runs.

Last price: $67.04
Sector: Healthcare
12-month range: $33.95–$65.23

Derived indicators

Coarse bands from TickrTrends' weekly models; exact figures are part of the full report.

Quality grade: F
Leverage: Moderate
Margin trend: Contracting
Revenue growth: Strong
RSI zone: Neutral
52-week position: The top quarter of its range

What our data shows for CNC

Our model validated 17 trailing price-to-earnings windows for CNC, built from quarterly earnings records.
Shares are trading in the upper third of their 12-month price range of $33.95–$65.23.
The 14-day relative strength index sits at a neutral 52.

The exact numbers are one step away

The precise Forward Fair Value dollar figure for CNC
Exact discount / premium to today's price
The normalized historical P/E behind the estimate, and how many quarters support it
Forward EPS input and fiscal-year basis
Screeners and rankings across the full S&P 500 and Nasdaq universes

See the exact fair value →

How Forward Fair Value works

TickrTrends computes a Forward Fair Value for every covered stock each week: a conservatively normalized historical price-to-earnings multiple is applied to the analyst-consensus earnings estimate for the next full fiscal year. Every input window is validated for continuity and every result is screened for plausibility before publication.

Recent CNC news

TickrTrends' derived news-sentiment signal for CNC is currently leaning positive, computed from recent coverage.

Centene: Rapid Earnings Recovery And Momentum (NYSE:CNC) (seekingalpha.com, 2026-09-09)
TickrTrends take: Centene's demonstrated earnings recovery suggests improving operational performance that could eventually justify a higher valuation, though the stock is currently trading above levels supported by traditional valuation metrics according to TickrTrends analysis. Healthcare companies undergoing earnings turnarounds often attract investor attention, which can create a gap between market price and fundamental value metrics. For valuation-focused investors, monitoring whether Centene's earnings momentum sustains and whether the stock's premium pricing narrows would be key factors in reassessing the overvaluation verdict.
Centene Stock: Profitability Recovery Is Not Fully Priced In (NYSE:CNC) (seekingalpha.com, 2026-09-09)
TickrTrends take: Centene Corporation trades at a valuation that TickrTrends currently assesses as overvalued despite the company's path toward improved profitability. For investors focused on valuation metrics, the gap between current pricing and the potential upside from a sustained earnings recovery represents a key risk-reward consideration in the Healthcare sector. Monitoring whether the company's profitability gains accelerate or decelerate will be important to determining whether the valuation multiple compresses or expands from current levels.
CNC Looks 13.2% Undervalued on GF Value™ Amid Strategic Shift (gurufocus.com, 2026-09-03)
TickrTrends take: CNC's valuation assessment presents a mixed picture, with the GF Value model suggesting meaningful undervaluation while TickrTrends currently classifies the stock as overvalued, indicating divergent analytical perspectives on the Healthcare sector company. A valuation-focused reader should monitor how CNC's strategic shift develops and whether it translates into fundamental improvements that could help reconcile these conflicting valuations. The discrepancy between these two analytical frameworks suggests investors should track earnings trends and operational execution closely to determine which valuation view proves more durable.

What people are saying

Follow the CNC conversation: Stocktwits · Reddit · X

TickrTrends weekly updates

2026-09-07 — No material change this week: the verdict, bands and grades all held steady.
2026-09-06 — TickrTrends' derived indicators for CNC in the Healthcare sector showed a shift this week in the DCF cross-check band assessment, which moved from overvalued to none. The current valuation verdict remains overvalued.
2026-08-31 — TickrTrends initiated weekly Forward Fair Value coverage of this stock.

Frequently asked questions

Is CNC stock undervalued?

Based on TickrTrends' Forward Fair Value model (updated 2026-09-07), CNC is trading at a 10–25% premium to estimated fair value and screens as overvalued. The exact fair value and discount are available to subscribers.

What is CNC's TickrTrends verdict?

CNC's current verdict is Overvalued, refreshed with every weekly Forward Fair Value run.

How does CNC compare to other Healthcare stocks?

CNC ranks #96 of 113 Healthcare stocks in TickrTrends' coverage when sorted by discount to Forward Fair Value.

Is CNC overbought or oversold?

CNC's 14-day RSI is in neutral territory - neither overbought nor oversold.

All Healthcare fair-value coverage →

Head-to-head comparisons

CNC vs BMY · CNC vs CAH · CNC vs CRL · CNC vs CVS · CNC vs ILMN